Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis

Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV

Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda

Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV

Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV

Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality

Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women

Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure

Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)

Florence Riako Anam and Bruce Richman on U=U

Peter Hayward on 10 years of The Lancet HIV

Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa

José M. Zuniga on the future of urban HIV responses Commission

Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)

Serge Eholie on treatments for HIV-2

Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana

Adam Trickey on trends in causes of death among people with HIV in Europe and North America

Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK

Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women